Makcin Sr

Clarithromycin, the active ingredient in Makcin Sr, is a macrolide antibiotic presented as an oral dosage form for oral use. It treats bacterial infections such as community‑acquired pneumonia, sinusitis, bronchitis, skin infections and is used in combination regimens for Helicobacter pylori eradication.

GNH USA supplies Makcin Sr as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Clarithromycin is employed to treat bacterial infections across several organ systems.

Community‑acquired pneumonia: clears the infection and improves respiratory function. Acute bacterial sinusitis: reduces sinus inflammation and bacterial load. Acute bacterial bronchitis: alleviates cough and resolves the underlying infection. Skin and soft‑tissue infections: eradicates causative bacteria and promotes healing. Helicobacter pylori eradication (in combination therapy): contributes to bacterial clearance as part of a multi‑drug regimen.

Clarithromycin may cause a range of adverse reactions, from mild to severe.

Common Side Effects: - Nausea - Diarrhea - Abdominal pain - Altered taste perception - Headache - Vomiting

Serious or Rare Side Effects: - QT interval prolongation and arrhythmias - Severe allergic reactions including anaphylaxis - Clostridioides difficile‑associated colitis - Hepatotoxicity - Stevens‑Johnson syndrome or toxic epidermal necrolysis - Hepatic enzyme elevations

Before prescribing clarithromycin, clinicians should consider several safety factors.

Assess liver function: monitor hepatic enzymes in patients with liver disease. Evaluate cardiac risk: avoid in patients with known QT prolongation or electrolyte disturbances. Check for macrolide allergy: discontinue if hypersensitivity occurs. Consider renal impairment: dose adjustment may be needed in severe renal dysfunction. Review concomitant medications: be aware of potential drug‑drug interactions. Store below 25°C: keep in the original container, protect from moisture and light.

Clarithromycin interacts with several medicines; some require avoidance while others need close monitoring.

Major Interactions (Avoid): - Cisapride: risk of serious cardiac arrhythmias. - Pimozide: may cause QT prolongation and ventricular tachycardia. - Ergot alkaloids: can precipitate ergotism. - Certain antiarrhythmics (e.g., quinidine): increased plasma levels. - Colchicine: heightened toxicity risk.

Moderate Interactions (Monitor Closely): - Simvastatin and lovastatin: increased statin concentrations, monitor for myopathy. - Warfarin: enhanced anticoagulant effect, check INR regularly. - Digoxin: elevated digoxin levels, observe for toxicity. - Oral hypoglycemics: possible hypoglycemia, adjust glucose monitoring.